Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12-MedSci.cn

Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12

Gottlieb, AB; Saure, D; Wilhelm, S; Dossenbach, M; Schuster, C; Smith, SD; Ramot, Y; Thaci, D

Gottlieb, AB (通讯作者)，Icahn Sch Med Mt Sinai, Dept Dermatol, 10 Union Sq East, New York, NY 10029 USA.

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (1): 54

科室
- - 订阅+
  - 更多科室
工具
服务